Invest in

Biotech Breakthroughs

13.6%
5.9%
0.0%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See more
13.6%
5.9%
0.0%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Biotech Breakthroughs Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
34.9% Cancer 20.0%
17.8% Amgen Inc. AMGN 12.7%
15.1% Celgene Corporation CELG 29.0%
1.1% Seattle Genetics Inc. SGEN 30.0%
1.0% SciClone Pharmaceuticals Inc. SCLN 4.3%
19.5% Other Diseases 38.0%
7.0% Regeneron Pharmaceuticals Inc. REGN 34.4%
4.9% Vertex Pharmaceuticals Incorporated VRTX 82.7%
4.8% Alexion Pharmaceuticals Inc. ALXN 0.3%
1.8% United Therapeutics Corporation UTHR 18.4%
1.0% Repligen Corporation RGEN 61.3%
16.8% Research & Diagnostics 16.8%
6.9% Quintiles IMS Holdings Inc. Q 26.1%
3.2% Illumina Inc. ILMN 12.7%
3.1% Charles River Laboratories International Inc. CRL 16.2%
2.7% Bio-Techne Corp TECH 6.2%
0.9% Luminex Corporation LMNX 5.4%
15.6% Autoimmune Disorders 18.7%
8.0% Biogen Inc. BIIB 7.5%
3.5% Incyte Corporation INCY 54.0%
2.9% BioMarin Pharmaceutical Inc. BMRN 7.0%
1.2% Galapagos NV Spons ADR GLPG 51.2%
12.2% Infectious Diseases 12.9%
12.2% Gilead Sciences Inc. GILD 12.9%
1.0% Cardiovascular 64.0%
1.0% Reata Pharmaceuticals Inc RETA 64.0%

Quotes delayed 15 mins. Currently Jul 21, 2017 4:33:39 AM. Fields are marked with -- when data is unavailable.